588 results on '"Hirtz, Christophe"'
Search Results
2. Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up
3. Readthrough isoform of aquaporin-4 (AQP4) as a therapeutic target for Alzheimer’s disease and other proteinopathies
4. Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer’s disease diagnosis in a memory clinic cohort
5. A sensitive high-resolution mass spectrometry method for quantifying intact M-protein light chains in patients with multiple myeloma
6. Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application
7. Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
8. Modeling the Simultaneous Dynamics of Proteins in Blood Plasma and the Cerebrospinal Fluid in Human In Vivo
9. Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells
10. CSF β-amyloid is not a prognostic marker in multiple sclerosis patients
11. Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
12. β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
13. A candidate reference measurement procedure for the quantification of α-synuclein in cerebrospinal fluid using an SI traceable primary calibrator and multiple reaction monitoring.
14. Enabling population protein dynamics through Bayesian modeling.
15. Intra-articular delivery of full-length antibodies through the use of an in situ forming depot
16. Cytokines as new biomarkers of skin wound vitality
17. Dual CRALBP isoforms unveiled: iPSC-derived retinal modelling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy
18. Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?
19. Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection
20. Efficient extraction of intact HSA-Aβ peptide complexes from sera: Toward albuminome biomarker identification
21. Hypoxemia increases blood-brain barrier permeability during extreme apnea in humans
22. Increasing the sensitivity of Simoa via bead count reduction facilitates the quantification of pTau‐181 in dried plasma spots
23. Post-polio syndrome is not a dysimmune condition
24. Routes to standardisation for tau protein measurement in CSF
25. Use of dried blood spots for monitoring inflammatory and nutritional biomarkers in the elderly
26. FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
27. Variation of human salivary alpha-amylase proteoforms in three stimulation models
28. Immunoassay and Mass Spectrometry Methods for Tau Protein Quantification in the Cerebrospinal Fluid
29. Ghrelin and adipokines: An overview of their physiological role, antimicrobial activity and impact on cardiovascular conditions
30. Use of dried blood spots for monitoring inflammatory and nutritional biomarkers in the elderly.
31. Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation.
32. Ultrasensitive digital immunoassays for SOD1 conformation in amyotrophic lateral sclerosis
33. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
34. Nano-flow vs standard-flow: Which is the more suitable LC/MS method for quantifying hepcidin-25 in human serum in routine clinical settings?
35. Towards a routine application of Top-Down approaches for label-free discovery workflows
36. Bystander effectors of chondrosarcoma cells irradiated at different LET impair proliferation of chondrocytes
37. SILK studies — capturing the turnover of proteins linked to neurodegenerative diseases
38. Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
39. Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial
40. Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges
41. Absolute quantification of synuclein proteoforms in plasma in patients with Synucleinopathies by LC-MRM mass spectrometry
42. Lower systemic nitric oxide bioactivity, cerebral hypoperfusion and accelerated cognitive decline in formerly concussed retired rugby union players
43. NICOTIANAMINE SYNTHASE activity affects nucleolar iron accumulation and impacts rDNA silencing and RNA methylation in Arabidopsis
44. Viral and immune dynamics of HPV genital infections in young women
45. Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process
46. Characterizing Deep White Matter Hyperintensities in Patients with Symptomatic Isolated Cortical Superficial Siderosis
47. Hepcidin and ferritin levels in restless legs syndrome: a case–control study
48. Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
49. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
50. Stable Isotope Labeling Kinetics in CNS Translational Medicine: Introduction to SILK Technology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.